Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07382557
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Surveys — OTHER
    Investigators will answer surveys about their lung cancer screening practices
  • Focus groups — OTHER
    Participants will participate in focus groups about information they need in order to decide about lung cancer screening
  • Cognitive Interviews — OTHER
    Participants will participate in interviews about their understanding of the adapted video script
  • Lung cancer screening decision aid video — BEHAVIORAL
    Participants take surveys before and after watching the intervention video
  • Colon cancer screening video — BEHAVIORAL
    Participants take surveys before and after watching the control video

Study Details

The goal of the study is to adapt and test a participant decision aid about lung cancer screening for use with patients in theHarris Health System (HHS).

Key Dates

Start date
Sep 29, 2022
Status verified
Jan 2026
Primary completion
Feb 2, 2027
Completion
Feb 2, 2027

Study Design

Enrollment
360 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Other: Needs Assessment: Provider Survey (Aim 1)
    Up to 200 physicians and other health professionals
  • Other: Needs Assessment: Patient/Family member Focus Groups (Aim 1)
    Up to 20 participants who speak English or Spanish
  • Other: Decision Aid Adaptation (Patient Cognitive Interviews (Aim 1)
    Up to 40 participants who speak English or Spanish
  • Experimental: Pilot Study: Intervention Patients (Aim 2)
    Up to 50 participants (25 English speakers, 25 Spanish speakers)
  • Placebo Comparator: Pilot Study: Control Patients (Aim 2)
    Up to 50 participants (25 English speakers, 25 Spanish speakers)

Primary Outcome Measure

Safety and Adverse Events (AEs). [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas M. D. Anderson Cancer CenterHoustonTexas77030
Robert Volk, PHD
[email protected]
713-563-2509
Robert Volk, PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
The University of Texas M. D. Anderson Cancer Center· Houston, TX

Related Studies